Atai Life Sciences N.V. (ATAI): Bathi resik saben saham sajrone 12 wulan pungkasan

Simbol lan logo merek Atai Life Sciences N.V. (ATAI)

Atai Life Sciences N.V. (ATAI) is developing an advanced R&D pipeline of psychedelic therapies for depression. The rolling trailing twelve-month earnings per share on the GURU.Markets chart reflects the impact of decentralized asset management and the leadership's scientific expertise, although geopolitical tensions and logistical disruptions are hindering global trials. The current value of -2.21 determines this specific profit parameter level.

ATAI (atai) riwayat Bathi resik saben saham sajrone 12 wulan pungkasan saka 04.07.2022 nganti 26.09.2026

Rincian analitis lan laporan data perusahaan atai Life Sciences Corp (ATAI)

- kuotasi saiki lan rata-rata prakiraan nilai:
Analisis kabeh metrik perusahaan:Atai Life Sciences N.V. - ATAI
Produk seri atai Life Sciences NV

Annual net income per share determines real business efficiency by dividing total income by the number of securities to identify the issuer's fundamental strength. By analyzing the current annual net income per share metric on GURU.Markets, an investor assesses the monetization potential of Atai Life Sciences N.V. (ATAI) innovations in the field of psychedelic therapy, where future government contracts are expected to transform investment expenditures into sustainable profit growth.